Nikcevic A, Sacchi C, Marino C, OGorman N, Poon L, Nicolaides K
Int J Environ Res Public Health. 2023; 20(7).
PMID: 37048032
PMC: 10094560.
DOI: 10.3390/ijerph20075418.
Plaszewski M
Int J Environ Res Public Health. 2022; 19(11).
PMID: 35682242
PMC: 9180347.
DOI: 10.3390/ijerph19116659.
Bobrowska A, Murton M, Seedat F, Visintin C, Mackie A, Steele R
Lancet Reg Health Eur. 2022; 16:100353.
PMID: 35492962
PMC: 9038565.
DOI: 10.1016/j.lanepe.2022.100353.
Plaszewski M, Grantham W, Jespersen E
World J Orthop. 2020; 11(9):364-379.
PMID: 32999857
PMC: 7507078.
DOI: 10.5312/wjo.v11.i9.364.
Sturdy S, Miller F, Hogarth S, Armstrong N, Chakraborty P, Cressman C
Wellcome Open Res. 2020; 5:158.
PMID: 32923689
PMC: 7468564.
DOI: 10.12688/wellcomeopenres.16057.2.
Translating insights into tumor evolution to clinical practice: promises and challenges.
Fittall M, Van Loo P
Genome Med. 2019; 11(1):20.
PMID: 30925887
PMC: 6440005.
DOI: 10.1186/s13073-019-0632-z.
.
Wilson B, Bell N, Grad R, Theriault G, Dickinson J, Singh H
Can Fam Physician. 2018; 64(11):e477-e482.
PMID: 30429191
PMC: 6234924.
Practice organization for preventive screening.
Wilson B, Bell N, Grad R, Theriault G, Dickinson J, Singh H
Can Fam Physician. 2018; 64(11):816-820.
PMID: 30429176
PMC: 6234927.
On the rationale of population screening for chronic kidney disease: a public health perspective.
Bochud M
Public Health Rev. 2018; 36:11.
PMID: 29450039
PMC: 5809894.
DOI: 10.1186/s40985-015-0009-9.
Management of Substance Use Disorder in Military Services: A Comprehensive Approach.
Sharbafchi M, Heydari M
Adv Biomed Res. 2017; 6:122.
PMID: 28989915
PMC: 5627564.
DOI: 10.4103/abr.abr_283_16.
Internalizing the threat of risk--a qualitative study about adolescents' experience living with screening-detected celiac disease 5 years after diagnosis.
Nordyke K, Rosen A, Emmelin M, Ivarsson A
Health Qual Life Outcomes. 2014; 12:91.
PMID: 24915870
PMC: 4081505.
DOI: 10.1186/1477-7525-12-91.
Li-Fraumeni syndrome: cancer risk assessment and clinical management.
McBride K, Ballinger M, Killick E, Kirk J, Tattersall M, Eeles R
Nat Rev Clin Oncol. 2014; 11(5):260-71.
PMID: 24642672
DOI: 10.1038/nrclinonc.2014.41.
Screening programmes for chlamydial infection: when will we ever learn?.
Low N
BMJ. 2007; 334(7596):725-8.
PMID: 17413173
PMC: 1847869.
DOI: 10.1136/bmj.39154.378079.BE.
Screening chest radiography: results from a Greek cross-sectional survey.
Kamposioras K, Casazza G, Mauri D, Lakiotis V, Cortinovis I, Xilomenos A
BMC Public Health. 2006; 6:113.
PMID: 16646992
PMC: 1513384.
DOI: 10.1186/1471-2458-6-113.
Evaluating novel interventions for chlamydia screening.
Low N
Sex Transm Infect. 2006; 82(2):97-8.
PMID: 16581729
PMC: 2564701.
DOI: 10.1136/sti.2005.017889.
New concepts in screening.
House W, Peters D
Br J Gen Pract. 2004; 54(506):705.
PMID: 15353065
PMC: 1326079.
